Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Dura forecasts Ceclor CD, Keftab sales of $100 mil. in 2000 following acquisition from Lilly.
Aug 26 1996
•
By
The Pink Sheet
More from Archive
More from Pink Sheet